Codexis, Inc.

NasdaqGS:CDXS 주식 보고서

시가총액: US$211.7m

이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

Codexis 관리

관리 기준 확인 1/4

Codexis' CEO는 Stephen Dilly, Aug2022 에 임명되었습니다 의 임기는 1.83 년입니다. 총 연간 보상은 $ 3.64M, 19.5% 로 구성됩니다. 19.5% 급여 및 80.5% 보너스(회사 주식 및 옵션 포함). 는 $ 1.25M 가치에 해당하는 회사 주식의 0.65% 직접 소유합니다. 1.25M. 경영진과 이사회의 평균 재임 기간은 각각 1.8 년과 2.5 년입니다.

주요 정보

Stephen Dilly

최고 경영자

US$3.6m

총 보상

CEO 급여 비율19.5%
CEO 임기1.8yrs
CEO 소유권0.6%
경영진 평균 재임 기간1.8yrs
이사회 평균 재임 기간2.5yrs

최근 관리 업데이트

Recent updates

Investors Appear Satisfied With Codexis, Inc.'s (NASDAQ:CDXS) Prospects

May 29
Investors Appear Satisfied With Codexis, Inc.'s (NASDAQ:CDXS) Prospects

Codexis, Inc.'s (NASDAQ:CDXS) Shares Leap 56% Yet They're Still Not Telling The Full Story

Dec 20
Codexis, Inc.'s (NASDAQ:CDXS) Shares Leap 56% Yet They're Still Not Telling The Full Story

What Does Codexis, Inc.'s (NASDAQ:CDXS) Share Price Indicate?

Dec 19
What Does Codexis, Inc.'s (NASDAQ:CDXS) Share Price Indicate?

Is Codexis (NASDAQ:CDXS) In A Good Position To Deliver On Growth Plans?

Nov 15
Is Codexis (NASDAQ:CDXS) In A Good Position To Deliver On Growth Plans?

Lacklustre Performance Is Driving Codexis, Inc.'s (NASDAQ:CDXS) Low P/S

Jun 28
Lacklustre Performance Is Driving Codexis, Inc.'s (NASDAQ:CDXS) Low P/S

Calculating The Intrinsic Value Of Codexis, Inc. (NASDAQ:CDXS)

Jun 07
Calculating The Intrinsic Value Of Codexis, Inc. (NASDAQ:CDXS)

At US$3.41, Is It Time To Put Codexis, Inc. (NASDAQ:CDXS) On Your Watch List?

May 09
At US$3.41, Is It Time To Put Codexis, Inc. (NASDAQ:CDXS) On Your Watch List?

Analysts Just Made A Major Revision To Their Codexis, Inc. (NASDAQ:CDXS) Revenue Forecasts

Feb 27
Analysts Just Made A Major Revision To Their Codexis, Inc. (NASDAQ:CDXS) Revenue Forecasts

We're Not Worried About Codexis' (NASDAQ:CDXS) Cash Burn

Feb 25
We're Not Worried About Codexis' (NASDAQ:CDXS) Cash Burn

Is Codexis, Inc. (NASDAQ:CDXS) Trading At A 28% Discount?

Nov 05
Is Codexis, Inc. (NASDAQ:CDXS) Trading At A 28% Discount?

Codexis appoints Kevin Norrett as chief operating officer

Oct 03

We Think Codexis (NASDAQ:CDXS) Can Afford To Drive Business Growth

Aug 23
We Think Codexis (NASDAQ:CDXS) Can Afford To Drive Business Growth

Analysts Have Just Cut Their Codexis, Inc. (NASDAQ:CDXS) Revenue Estimates By 10%

Jul 28
Analysts Have Just Cut Their Codexis, Inc. (NASDAQ:CDXS) Revenue Estimates By 10%

Codexis: Profitability, Return On Capital Are Persistent Headwinds Looking Ahead

Jul 27

Codexis gets new executive chief

Jul 18

Are Investors Undervaluing Codexis, Inc. (NASDAQ:CDXS) By 35%?

Jul 06
Are Investors Undervaluing Codexis, Inc. (NASDAQ:CDXS) By 35%?

Why Codexis, Inc. (NASDAQ:CDXS) Could Be Worth Watching

May 10
Why Codexis, Inc. (NASDAQ:CDXS) Could Be Worth Watching

CEO 보상 분석

Stephen Dilly 의 보수는 Codexis 의 수익과 비교하여 어떻게 변경되었나요?
날짜총 보상급여회사 수익
Mar 31 2024n/an/a

-US$65m

Dec 31 2023US$4mUS$710k

-US$76m

Sep 30 2023n/an/a

-US$82m

Jun 30 2023n/an/a

-US$57m

Mar 31 2023n/an/a

-US$48m

Dec 31 2022US$6mUS$279k

-US$34m

Sep 30 2022n/an/a

-US$31m

Jun 30 2022n/an/a

-US$19m

Mar 31 2022n/an/a

-US$21m

Dec 31 2021US$175kn/a

-US$21m

Sep 30 2021n/an/a

-US$15m

Jun 30 2021n/an/a

-US$23m

Mar 31 2021n/an/a

-US$25m

Dec 31 2020US$241kn/a

-US$24m

보상 대 시장: Stephen 의 총 보상 ($USD 3.64M )은 US 시장( $USD 1.62M ).

보상과 수익: Stephen 의 보상은 지난 한 해 동안 회사 성과와 일치했습니다.


CEO

Stephen Dilly (64 yo)

1.8yrs

테뉴어

US$3,638,098

보상

Dr. Stephen George Dilly, M.B.B.S, Ph D., has been Independent Director of Codexis, Inc. since June 16, 2020 and also has been its President and Chief Executive Officer since August 2022. He serves as Dire...


리더십 팀

이름위치테뉴어보상소유권
Stephen Dilly
President1.8yrsUS$3.64m0.65%
$ 1.4m
Sriram Ryali
Chief Financial Officer1.4yrsUS$2.78m0.091%
$ 193.3k
Kevin Norrett
Chief Operating Officer1.7yrsUS$1.09m0.17%
$ 353.6k
Carrie McKim
Director of Investor Relationsno data데이터 없음데이터 없음
Margaret Fitzgerald
Chief Legal & Compliance Officer1.6yrsUS$2.18m0.049%
$ 104.4k
Karen Frechou-Armijo
Senior VP & Head of Human Resources2.6yrs데이터 없음데이터 없음
Stefan Lutz
Senior Vice President of Research4.1yrs데이터 없음데이터 없음
Robert Sato
Senior Vice President of Pharmaceutical Development3.9yrs데이터 없음데이터 없음

1.8yrs

평균 재임 기간

52yo

평균 연령

경험이 풍부한 관리: CDXS 의 관리팀은 경험 (평균 재직 기간 1.8 년)으로 간주되지 않으므로 새로운 팀을 추천합니다.


이사회 구성원

이름위치테뉴어보상소유권
Stephen Dilly
President4yrsUS$3.64m0.65%
$ 1.4m
H. Parker
Independent Director1.5yrsUS$180.00k0.15%
$ 307.8k
John M. Maraganore
Member of Strategic Advisory Boardless than a year데이터 없음데이터 없음
David Smith
Independent Director8.3yrsUS$195.00k0.22%
$ 459.9k
Carole Cobb
Member of Strategic Advisory Boardless than a year데이터 없음데이터 없음
Dennis Wolf
Independent Director16.5yrsUS$190.00k0.15%
$ 320.8k
Rahul Singhvi
Independent Director1.7yrsUS$196.73k0.14%
$ 288.2k
James Lalonde
Member of Strategic Advisory Boardless than a yearUS$1.02m데이터 없음
Masad Damha
Member of Strategic Advisory Boardless than a year데이터 없음데이터 없음
Byron Dorgan
Independent Chairman13.3yrsUS$222.75k0.32%
$ 670.7k
Alison Moore
Independent Director4yrsUS$190.00k0.14%
$ 296.1k
Esther Martinborough
Independent Director3.3yrsUS$175.00k0.12%
$ 264.2k

2.5yrs

평균 재임 기간

64yo

평균 연령

경험이 풍부한 이사회: CDXS 의 이사회경험(평균 재직 기간 2.5 년)으로 간주되지 않으므로 새 이사회가 필요합니다.